Invivyd, Inc. (IVVD)
NASDAQ: IVVD · Real-Time Price · USD
1.710
+0.090 (5.56%)
At close: Mar 4, 2026, 4:00 PM EST
1.730
+0.020 (1.17%)
After-hours: Mar 4, 2026, 7:33 PM EST
Invivyd Market Cap
Invivyd has a market cap or net worth of $482.2 million as of March 4, 2026. Its market cap has increased by 176.11% in one year.
Market Cap
482.20M
Enterprise Value
399.91M
1-Year Change
176.11%
Ranking
Category
Stock Price
$1.71
Market Cap Chart
Since August 6, 2021, Invivyd's market cap has decreased from $2.27B to $482.20M, a decrease of -78.72%. That is a compound annual growth rate of -28.68%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 4, 2026 | 482.20M | -29.55% |
| Dec 31, 2025 | 684.49M | 1,191.45% |
| Dec 31, 2024 | 53.00M | -87.78% |
| Dec 29, 2023 | 433.85M | 165.40% |
| Dec 30, 2022 | 163.47M | -79.76% |
| Dec 31, 2021 | 807.69M | -64.36% |
| Aug 6, 2021 | 2.27B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Zevra Therapeutics | 511.74M |
| Prothena Corporation | 506.03M |
| Eupraxia Pharmaceuticals | 498.56M |
| Kyverna Therapeutics | 486.46M |
| Solid Biosciences | 483.04M |
| Vanda Pharmaceuticals | 482.91M |
| 4D Molecular Therapeutics | 475.90M |
| Lineage Cell Therapeutics | 472.54M |